VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30006048 | HIV | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
TVIS30031847 | HIV | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
TVIS30031848 | HIV | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
TVIS30031849 | HIV | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
TVIS30031850 | HIV | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
TVIS30031851 | HIV | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
TVIS44017494 | HTLV-1 | ENSG00000139180.11 | protein_coding | NDUFA9 | No | No | 4704 | Q16795 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | NDUFA9 |
---|---|
DrugBank ID | DB03147 |
Drug Name | Flavin adenine dinucleotide |
Target ID | BE0000305 |
UniProt ID | Q16795 |
Regulation Type | cofactor |
PubMed IDs | 25526675 |
Citations | Bhatia C, Oerum S, Bray J, Kavanagh KL, Shafqat N, Yue W, Oppermann U: Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships. Chem Biol Interact. 2015 Jun 5;234:114-25. doi: 10.1016/j.cbi.2014.12.013. Epub 2014 Dec 16. |
Groups | Approved |
Direct Classification | Flavin nucleotides |
SMILES | CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2 |
Pathways | Cerivastatin Action Pathway; Ethylmalonic Encephalopathy; 3-Methylglutaconic Aciduria Type III; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Caffeine Metabolism; Isovaleric Aciduria; Lysine Degradation; Riboflavin Metabolism; 5-Oxoprolinuria; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Glycerol Phosphate Shuttle; Propionic Acidemia; Hypercholesterolemia; Xanthine Dehydrogenase Deficiency (Xanthinuria); S-Adenosylhomocysteine (SAH) Hydrolase Deficiency; Tryptophan Metabolism; Glutaric Aciduria Type I; 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Phenylketonuria; Glycine N-Methyltransferase Deficiency; Dimethylglycine Dehydrogenase Deficiency; Lovastatin Action Pathway; 3-Methylglutaconic Aciduria Type IV; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Glutathione Metabolism; Folate Metabolism; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease; Glycerol Kinase Deficiency; Adenylosuccinate Lyase Deficiency |
PharmGKB | |
ChEMBL | CHEMBL1232653 |